Payam Nahid

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Update in tuberculosis and nontuberculous mycobacterial disease 2011
    Payam Nahid
    Division of Pulmonary and Critical Care Medicine and Curry International Tuberculosis Center, University of California, San Francisco at San Francisco General Hospital, San Francisco, CA 94110, USA
    Am J Respir Crit Care Med 185:1266-70. 2012
  2. ncbi Clinical research and development of tuberculosis diagnostics: moving from silos to synergy
    Payam Nahid
    Division of Pulmonary and Critical Care Medicine, Department of Medicine at San Francisco General Hospital and Curry International Tuberculosis Center, University of California, San Francisco, CA 94110, USA
    J Infect Dis 205:S159-68. 2012
  3. ncbi Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
    Payam Nahid
    Curry International Tuberculosis Center, University of California, San Francisco, CA, USA
    BMC Infect Dis 11:1. 2011
  4. ncbi Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis
    Payam Nahid
    Division of Pulmonary and Critical Care Medicine, Francis J Curry National Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA
    PLoS ONE 5:e10753. 2010
  5. ncbi Racial differences in tuberculosis infection in United States communities: the coronary artery risk development in young adults study
    Payam Nahid
    Curry International Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, California, USA
    Clin Infect Dis 53:291-4. 2011
  6. ncbi CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap
    Payam Nahid
    Division of Pulmonary and Critical Care, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, CA 94110, USA
    Am J Respir Crit Care Med 184:972-9. 2011
  7. ncbi Treatment outcomes of patients with HIV and tuberculosis
    Payam Nahid
    University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, 5K1, San Francisco, CA 94110, USA
    Am J Respir Crit Care Med 175:1199-206. 2007
  8. ncbi Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco GeneralHospital, 1001 Potrero Ave, San Francisco, CA 94110, USA
    Clin Infect Dis 48:179-85. 2009
  9. ncbi Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis
    David J Horne
    Division of Pulmonary and Critical Care Medicine, Seattle, WA 98104, USA
    Lancet Infect Dis 10:387-94. 2010
  10. ncbi Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response
    Amador Goodridge
    Division of Infectious Diseases and Vaccinology, School of Public Health, 201 Hildebrand Hall, University of California, Berkeley, CA 94720, USA
    Tuberculosis (Edinb) 92:243-7. 2012

Research Grants

  1. Interplay of strain and ethnicity in the immune response to M. tuberculosis
    Payam Nahid; Fiscal Year: 2007

Detail Information

Publications20

  1. ncbi Update in tuberculosis and nontuberculous mycobacterial disease 2011
    Payam Nahid
    Division of Pulmonary and Critical Care Medicine and Curry International Tuberculosis Center, University of California, San Francisco at San Francisco General Hospital, San Francisco, CA 94110, USA
    Am J Respir Crit Care Med 185:1266-70. 2012
    ..Advances in understanding TB epidemiology diagnosis and treatment in 2011, many of which were reported in the Journal, provide hope that the annual decline in TB cases will accelerate...
  2. ncbi Clinical research and development of tuberculosis diagnostics: moving from silos to synergy
    Payam Nahid
    Division of Pulmonary and Critical Care Medicine, Department of Medicine at San Francisco General Hospital and Curry International Tuberculosis Center, University of California, San Francisco, CA 94110, USA
    J Infect Dis 205:S159-68. 2012
    ....
  3. ncbi Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
    Payam Nahid
    Curry International Tuberculosis Center, University of California, San Francisco, CA, USA
    BMC Infect Dis 11:1. 2011
    ..Tuberculosis is a leading cause of death worldwide, yet the determinants of death are not well understood. We sought to determine risk factors for mortality during treatment of drug-susceptible pulmonary tuberculosis under program settings...
  4. ncbi Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis
    Payam Nahid
    Division of Pulmonary and Critical Care Medicine, Francis J Curry National Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA
    PLoS ONE 5:e10753. 2010
    ..Disease presentation and response to drug treatment varied by lineage, but these associations were no longer statistically significant after adjustment for other variables associated with week-8 culture status...
  5. ncbi Racial differences in tuberculosis infection in United States communities: the coronary artery risk development in young adults study
    Payam Nahid
    Curry International Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, California, USA
    Clin Infect Dis 53:291-4. 2011
    ..0; 95% confidence interval, 1.5-2.9)...
  6. ncbi CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap
    Payam Nahid
    Division of Pulmonary and Critical Care, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, CA 94110, USA
    Am J Respir Crit Care Med 184:972-9. 2011
    ..This article summarizes these recommendations and provides a roadmap for their implementation...
  7. ncbi Treatment outcomes of patients with HIV and tuberculosis
    Payam Nahid
    University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, 5K1, San Francisco, CA 94110, USA
    Am J Respir Crit Care Med 175:1199-206. 2007
    ..The optimal length of tuberculosis treatment in patients coinfected with HIV is unknown...
  8. ncbi Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco GeneralHospital, 1001 Potrero Ave, San Francisco, CA 94110, USA
    Clin Infect Dis 48:179-85. 2009
    ..Risk factors and treatment outcomes under program conditions for isoniazid (INH)-monoresistant tuberculosis have not been well described...
  9. ncbi Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis
    David J Horne
    Division of Pulmonary and Critical Care Medicine, Seattle, WA 98104, USA
    Lancet Infect Dis 10:387-94. 2010
    ..Although we pooled a diverse group of patients, the individual studies had similar performance characteristics. Better predictive markers are needed...
  10. ncbi Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response
    Amador Goodridge
    Division of Infectious Diseases and Vaccinology, School of Public Health, 201 Hildebrand Hall, University of California, Berkeley, CA 94720, USA
    Tuberculosis (Edinb) 92:243-7. 2012
    ..The measurement of IgM anti-phospholipid antibodies may be a useful biomarker to monitor treatment response in non-cavitary TB patients...
  11. ncbi Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis
    Raymund Dantes
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 7:e37956. 2012
    ..Specific isoniazid (INH) resistance conferring mutations have been shown to impact the likelihood of tuberculosis (TB) transmission. However, their role in the clinical presentation and outcomes of TB has not been evaluated...
  12. ncbi Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosis-control program perspective
    Nicholas D Walter
    Division of Pulmonary and Critical Care, San Francisco General Hospital, University of California, San Francisco, 94110, USA
    Clin Infect Dis 46:103-6. 2008
    ..We report that 62% of these cases were not preventable and conclude that a further reduction in the incidence of tuberculosis among foreign-born persons will be modest without modification of current guidelines...
  13. ncbi Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection
    Adithya Cattamanchi
    University of California San Francisco, San Francisco General Hospital, San Francisco, CA 94110, USA
    Chest 133:875-80. 2008
    ..In patients with HIV infection, the radiographic findings of M kansasii lung disease are not well described...
  14. ncbi Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects
    John Z Metcalfe
    San Francisco General Hospital, University of California, 94110 0111, USA
    Am J Respir Crit Care Med 181:87-93. 2010
    ..Objectives: To determine whether the addition of quantitative IGRA results to a prediction model incorporating clinical criteria improves risk stratification of smear-negative-tuberculosis suspects...
  15. ncbi Prevention of tuberculosis in HIV-infected patients
    Payam Nahid
    Division of Pulmonary and Critical Care Medicine, University of California-San Francisco, San Francisco General Hospital, San Francisco, CA, USA
    Curr Opin Infect Dis 19:189-93. 2006
    ....
  16. ncbi Novel hot spot of IS6110 insertion in Mycobacterium tuberculosis
    Elizabeth Y Kim
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, San Francisco General Hospital, Francis J Curry National Tuberculosis Center, University of California, San Francisco, California, USA
    J Clin Microbiol 48:1422-4. 2010
    ..Because RD724 defines sublineage 724 of M. tuberculosis, caution must be exercised when screening for RD724, as different polymorphisms can be observed in this region...
  17. ncbi Efficacy of nurse case-managed intervention for latent tuberculosis among homeless subsamples
    Adeline Nyamathi
    Audrienne H Moseley Endowed Chair in Community Health Research, School of Nursing, University of California, Los Angeles, CA 90095 1702, USA
    Nurs Res 57:33-9. 2008
    ....
  18. ncbi Advances in the diagnosis and treatment of tuberculosis
    Payam Nahid
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, 1001 Potrero Avenue, Room 5K1, San Francisco, CA 94110, USA
    Proc Am Thorac Soc 3:103-10. 2006
    ....
  19. ncbi Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis
    Karen R Steingart
    Francis J Curry National Tuberculosis Center, University of California, San Francisco, 3180 18th Street, Suite 101, San Francisco, CA 94110 2028, USA
    Clin Vaccine Immunol 16:260-76. 2009
    ..The use of a case-control design with healthy controls for the majority of studies was a limitation of the review. Efforts are needed to improve the methodological quality of tuberculosis diagnostic studies...
  20. ncbi Clinical practice. Latent tuberculosis infection
    Robert M Jasmer
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    N Engl J Med 347:1860-6. 2002

Research Grants2

  1. Interplay of strain and ethnicity in the immune response to M. tuberculosis
    Payam Nahid; Fiscal Year: 2007
    ..Neil Risch) and epidemiology (Drs. Dennis Osmond and Neil Risch). Together, these senior investigators represent the diversity of fields that are essential for my training and proposed research study. ..